Teva : TEVA

All Teva Articles

450 Articles

Jon C. Ogg | Jan 23, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amazon.com, Dell Technologies, IBM, International Paper, Merck, Pfizer,…

Chris Lange | Jan 11, 2019 at 9:50 AM EST

Major Pharma Sees Fading Short Interest

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 3, 2019 at 1:25 PM EST

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen…

Jon C. Ogg | Jan 3, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First…

Chris Lange | Dec 27, 2018 at 10:00 AM EST

Short Sellers Hike Bets in Major Pharma Stocks

The December 14 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 12, 2018 at 9:50 AM EST

Major Pharma Stocks See a Surge in Short Interest

The November 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 28, 2018 at 9:00 AM EST

Short Sellers Hike Their Bets in Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 12, 2018 at 10:10 AM EST

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 8, 2018 at 12:45 PM EST

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to…

Jon C. Ogg | Nov 5, 2018 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Adamas, Alibaba, Bluebird Bio, Chevron, Encana, Parsley Energy, Starbucks, Teva, Under Armour and More

The top analyst upgrades, downgrades and initiations seen on Monday included Adamas Pharmaceuticals, Alibaba, Bluebird Bio, Chevron, Encana, Parsley Energy,…

Chris Lange | Nov 1, 2018 at 9:50 AM EDT

The Drag on Teva’s Q3 Results

Teva Pharmaceutical released its most recent earnings report before the markets opened on Thursday.

Chris Lange | Oct 28, 2018 at 7:15 AM EDT

Facebook, GE, Starbucks and More Major Earnings Coming This Week

We are in the midst of earnings season, during which most major companies will report and set a direction for…

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Lee Jackson | Oct 1, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

The top analyst upgrades, downgrades and initiations seen on Monday included Amgen, Chipotle Mexican Grill, Lam Research, Netgear, Teva Pharmaceutical…

1 … 4 5 6 7 8 … 30

Teva : TEVA

All Teva Articles

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

Top Analyst Upgrades and Downgrades: Adamas, Alibaba, Bluebird Bio, Chevron, Encana, Parsley Energy, Starbucks, Teva, Under Armour and More

The Drag on Teva’s Q3 Results

Facebook, GE, Starbucks and More Major Earnings Coming This Week

Major Pharma Short Sellers Hike Their Bets

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

Teva : TEVA

All Teva Articles

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

Top Analyst Upgrades and Downgrades: Adamas, Alibaba, Bluebird Bio, Chevron, Encana, Parsley Energy, Starbucks, Teva, Under Armour and More

The Drag on Teva’s Q3 Results

Facebook, GE, Starbucks and More Major Earnings Coming This Week

Major Pharma Short Sellers Hike Their Bets

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan